GSK plc Share Repurchase

GSK plc announced that on April 8, 2026, it purchased 330,000 of its own ordinary shares at prices ranging from 2,105.00p to 2,140.00p, with a volume-weighted average price of 2,125.45p per share. These shares will be held as treasury shares. This transaction is part of the company's ongoing share buyback program, initiated under a non-discretionary agreement with BNP Paribas SA. Since February 17, 2026, GSK has repurchased a total of 17,566,521 ordinary shares. Following this latest purchase, the company holds 257,457,615 shares in treasury, with 4,058,726,834 ordinary shares remaining in issue. The total voting rights in the company are now 4,058,726,834, which shareholders can use for notification calculations. The percentage of voting rights held in treasury after this purchase is 6.34%. The filing also includes detailed information on individual trades executed on the London Stock Exchange and CBOE Europe.